— Know what they know.
Not Investment Advice
Also trades as: CMRAW (NASDAQ) · $vol 0M

CMRA OTC

Comera Life Sciences Holdings, Inc.
1W: -0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 53 · $3074 mcap · 14M float · 0.0070% daily turnover

Balance Sheet Trends

Total Assets
$4M -49.8% ▼
Total Liabilities
$10M -54.9% ▼
Shareholders Equity
-$6M -201.2% ▼
Cash & Investments
$447K -93.1% ▼
Total Debt
$775K +139.9% ▲
Net Debt
$328K +105.3% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022
— Assets —
Cash$155K$7M$447K
Short-Term Investments$0$0$0
Cash & ST Investments$155K$7M$447K
Net Receivables$110K$222K$34K
Inventory$22K$2K$0
Other Current Assets$1K$49K$2M
Total Current Assets$310K$7M$3M
Property, Plant & Equip.$178K$555K$571K
Goodwill & Intangibles$0$0$0
Long-Term Investments$107M$50K$50K
Other Non-Current Assets-$107M$32K$43K
Total Non-Current Assets$235K$637K$664K
Total Assets$546K$7M$4M
— Liabilities —
Accounts Payable$98K$417K$1M
Short-Term Debt$0$122K$456K
Deferred Revenue$29K$0$144K
Other Current Liabilities$1K$10K$2M
Total Current Liabilities$233K$1M$5M
Long-Term Debt$161K$0$0
Other Non-Current Liab.$0$21M$5M
Total Non-Current Liabilities$161K$21M$5M
Total Liabilities$394K$22M$10M
— Equity —
Common Stock$11M$31$2K
Retained Earnings-$11M-$17M-$35M
Accumulated OCI$0-$21M-$5M
Total Stockholders Equity$152K$6M-$6M
Total Liabilities & Equity$546K$7M$4M
— Key Metrics —
Total Debt$161K$323K$775K
Net Debt$5K-$6M$328K
Total Investments$107M$50K$50K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms